Arzu Hazal Aydin
Arzu Hazal Aydin has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Açelya Yilmazer
1 shared publication- Buse Bayazit Gözüküçük
Department of Pathology, Bilkent City Hospital, ANKARA, TURKEY
1 shared publication - Damla Alkaya
Ankara University
1 shared publication Derviş Duru
Ankara Bilkent City Hospital, General Surgery Department Üniversiteler Mah. Dumlupınar Cad, Çankaya, Ankara, Turkey
1 shared publicationEda Şahingöz
Ankara Bilkent City Hospital, General Surgery Department Üniversiteler Mah. Dumlupınar Cad, Çankaya, Ankara, Turkey
1 shared publication- Göktürk Gürsoy
Department of General Surgery, Ankara City Hospital
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by Elsevier in Current Problems in Surgery
- Vol. 82
Effect of Polypropylene Mesh with MXene-Containing Hydrogel on Adhesions in a Rat Hernia Model
- 24 June 2026
- Published by Elsevier in Current Problems in Surgery
- Vol. 82
Open AccessEffect of Polypropylene Mesh with MXene-Containing Hydrogel on Adhesions in a Rat Hernia Model
- Open Access
- 13 October 2025
- Published by Hitit University in Hitit Medical Journal
- Vol. 7 (3) , 461-464
Nodular Lymphoid Hyperplasia of the Gastrointestinal Tract with Selective IgA Deficiency in an Adult Patient: A Case Report
Nodular lymphoid hyperplasia of the gastrointestinal tract is a rare and benign condition which may accompany immunodeficiency. Although being benign, it carries risk for intestinal and extraintestinal lymphoma. There is no specific and definitive treatment for NLH. Thus, treatment is dependent on the management of the associated conditions. Duodenal and terminal ileal biopsies from a 54-year-old woman with multiple mesenteric lymphadenopathy and gastrointestinal lymphoid hyperplasia revealed nodular lymphoid hyperplasia as well as a paucity of plasma cells. Based on histopathological findings and laboratory results, a diagnosis of selective IgA deficiency was made. It is important to evaluate patients with nodular lymphoid hyperplasia for additional histopathological findings due to the association with possible immune deficiency such as absence or scarcity of plasma cells.
- 13 October 2025
- Published by Hitit University in Hitit Medical Journal
- Vol. 7 (3) , 461-464
Open AccessNodular Lymphoid Hyperplasia of the Gastrointestinal Tract with Selective IgA Deficiency in an Adult Patient: A Case Report
Nodular lymphoid hyperplasia of the gastrointestinal tract is a rare and benign condition which may accompany immunodeficiency. Although being benign, it carries risk for intestinal and extraintestinal lymphoma. There is no specific and definitive treatment for NLH. Thus, treatment is dependent on the management of the associated conditions. Duodenal and terminal ileal biopsies from a 54-year-old woman with multiple mesenteric lymphadenopathy and gastrointestinal lymphoid hyperplasia revealed nodular lymphoid hyperplasia as well as a paucity of plasma cells. Based on histopathological findings and laboratory results, a diagnosis of selective IgA deficiency was made. It is important to evaluate patients with nodular lymphoid hyperplasia for additional histopathological findings due to the association with possible immune deficiency such as absence or scarcity of plasma cells.
- Open Access
- 26 February 2025
- Published by Elsevier in Surgery Open Science
- Vol. 24, 61-65
Evaluation of the necessity of simultaneous cholecystectomy in patients undergoing liver hydatid cyst surgery
- 26 February 2025
- Published by Elsevier in Surgery Open Science
- Vol. 24, 61-65
Open AccessEvaluation of the necessity of simultaneous cholecystectomy in patients undergoing liver hydatid cyst surgery
- Open Access
- 31 August 2023
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 25 (2) , 361-364
MUCOEPIDERMOID CARCINOMA OF THE LIVER: A RARE, DIAGNOSTICALLY CHALLENGING CASE
Mucoepidermoid carcinoma is the most common malignant tumor of the salivary gland. It rarely occurs in other organs. Less than 20 cases of mucoepidermoid carcinoma of liver have been reported in the literature. A 70-year-old woman with a liver mass is reported in this case report. After liver segmentectomy operation, the specimen was examined microscopically, a tumor consisting of epidermoid, mucinous, and intermediate cells was observed. It was interpreted as mucoepidermoid carcinoma. As no other focus was detected from comprehensive scanning of the patient, it was diagnosed as primary mucoepidermoid carcinoma of liver. Due to mimicking other tumors such as adenosquamous carcinoma and squamous cell carcinoma; cautious examination and differential diagnosis are important.
- 31 August 2023
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 25 (2) , 361-364
Open AccessMUCOEPIDERMOID CARCINOMA OF THE LIVER: A RARE, DIAGNOSTICALLY CHALLENGING CASE
Mucoepidermoid carcinoma is the most common malignant tumor of the salivary gland. It rarely occurs in other organs. Less than 20 cases of mucoepidermoid carcinoma of liver have been reported in the literature. A 70-year-old woman with a liver mass is reported in this case report. After liver segmentectomy operation, the specimen was examined microscopically, a tumor consisting of epidermoid, mucinous, and intermediate cells was observed. It was interpreted as mucoepidermoid carcinoma. As no other focus was detected from comprehensive scanning of the patient, it was diagnosed as primary mucoepidermoid carcinoma of liver. Due to mimicking other tumors such as adenosquamous carcinoma and squamous cell carcinoma; cautious examination and differential diagnosis are important.
- Open Access
- 30 April 2023
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 25 (1) , 166-169
STRONGYLOIDES STERCORALIS: A RARE CASE DIAGNOSED WITH ESOPHAGEAL SWAB SAMPLE
Strongyloides stercoralis is an opportunistic parasite that may cause severe and fatal disease in immunocompromised hosts. A 70-year-old man with a nonspecific history except pneumoconiosis had diffuse ulcers on the esophagus. Hence, only a swab sample could be performed. On microscopic examination of the swab sample, larvae and soils were observed in necrotic and inflammatory background. It was evaluated as compatible with S. stercoralis. At repeated endoscopic examination multiple biopsies were taken from the stomach. Larvae and soils were detected in crypt lumens with chronic inflammation in gastric mucosa. We presented this case with gastric involvement as a rare presentation that has not been reported in the literature before and was diagnosed by esophageal swab sample. Although infection is usually asymptomatic in the chronic phase, it carries a high mortality risk in immunocompromised hosts. So, it is important to scan the risk group. Swab sampling is an easy method for cytological examination.
- 30 April 2023
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 25 (1) , 166-169
Open AccessSTRONGYLOIDES STERCORALIS: A RARE CASE DIAGNOSED WITH ESOPHAGEAL SWAB SAMPLE
Strongyloides stercoralis is an opportunistic parasite that may cause severe and fatal disease in immunocompromised hosts. A 70-year-old man with a nonspecific history except pneumoconiosis had diffuse ulcers on the esophagus. Hence, only a swab sample could be performed. On microscopic examination of the swab sample, larvae and soils were observed in necrotic and inflammatory background. It was evaluated as compatible with S. stercoralis. At repeated endoscopic examination multiple biopsies were taken from the stomach. Larvae and soils were detected in crypt lumens with chronic inflammation in gastric mucosa. We presented this case with gastric involvement as a rare presentation that has not been reported in the literature before and was diagnosed by esophageal swab sample. Although infection is usually asymptomatic in the chronic phase, it carries a high mortality risk in immunocompromised hosts. So, it is important to scan the risk group. Swab sampling is an easy method for cytological examination.
- Open Access
- 27 March 2023
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 4 (2) , 158-162
HPV DNA pozitif olguların servikal smear ile korelasyon sonuçları her zaman uyumlu mudur?
Aim: Cervical cancer is a type of genital cancer which come second after breast cancer in women and may cause death. However, it can be prevented with screening tests by ensuring early diagnosis. Most of cervical cancers (99.7%) are associated with Human Papilloma Virus (HPV) and it is known that HPV must be present for the generation of cervical cancer. Thus, 70% of the patients have been found to be positive for HPV-16 and HPV-18. Both the association with cervical cancer and HPV and data related to development of cancer and dysplasia was researched retrospectively in this study. It was aimed to analyze and use the results by examine if the smear results of the patients and the HPV results are compatible in all HPV positive cases. Material and Method: 1050 patients who were examined by gynecologist and taken Pap smear test at the end of the examination during July 2020 and March 2022, were included in our study. In all cases the Pap test was re-evaluated by the same pathologist using the 2014 Bethesda System. High-risk HPV (HR HPV) DNA (HPV types 16,18,31,33,35,39,45,51,52,56,58,59,66,68) tests results, applied to the patients at an external center, were reviewed. Results of patients diagnosed as LSIL, HSIL and cervical cancer by Pap smear test were evaluated again beside HPV DNA analyses and their clinical information. Chi-square test was used for statistical analysis. p<0.05 values were considered statistically significant. Results: Of 1050 patients, 139 had LSIL, 170 had HSIL, and 112 had cervical cancer. The highest incidence of LSIL, HSIL and cancer was observed in the 30-39 age group, while the rate of these diseases was lower in the 50-59 age group compared to other groups. In addition, all patients with SIL and cervical cancer had smoking history. HR HPV DNA test was positive in 240 of 1050 patients. 56 patients diagnosed as LSIL and 89 patients diagnosed as HSIL by Pap smear had positive HR HPV DNA test results. HR HPV DNA positivity was reported in 74 of 112 patients with cervical cancer. In 21 patients who had normal smear test were detected HR HPV DNA positivity. 17 of these patients were in the 30-39 age group and 4 of them were in the 40-49 age group. Conclusions: Because of all 112 patients with cancer were not HR HPV positive and the smear results of 21 HR HPV positive patients were normal, our study serves an example for studies to show that the results of smear and HPV DNA in cervical cancer are not always compatible. Amaç: Serviks kanseri, ölüme neden olan ve meme kanserinden sonra kadınlarda en sık görülen ikinci kanserdir. Ancak tarama testleri ile erken teşhis edilerek önlenebilen bir genital kanser türüdür. Serviks kanserlerinin çoğu (%99,7) Human Papilloma Virus (HPV) ile ilişkili olup günümüzde de servikal kanser gelişimi için HPV’nin mutlaka olması gerektiği bilinmektedir. Nitekim hastaların %70’inde HPV-16 ve HPV-18’in pozitif olduğu tespit edilmiştir. Bu çalışmada servikal kanser-HPV ilişkisi, displazi ve kanser gelişme oranları ile ilgili veriler retrospektif olarak araştırılmıştır. HPV pozitif tüm olgularda hastaların smear sonuçları ile HPV sonuçlarının uyumlu olup olmadığı kontrol edilerek sonuçların analiz edilmesi ve kullanılması planlanmıştır. Materyal ve Metod: Çalışmaya Temmuz 2020 ve Mart 2022 tarihleri arasında jinekolog tarafından muayeneleri yapılmış ve muayene sonunda Pap smear örneği alınmış 1050 olgu dahil edilmiştir. Tüm olguların Pap smear testleri patolog tarafından 2014 Bethesda sistemi kullanılarak yeniden değerlendirilmiştir. Çalışmada yer alan hastalara dış merkezde uygulanan yüksek risk HPV (HR HPV) DNA (HPV tipleri 16,18,31,33,35,39,45,51,52,56,58,59,66,68) test sonuçları tekrar gözden geçirilmiştir. Pap testte düşük dereceli skuamöz intraepitelyal lezyon (LSIL), yüksek dereceli skuamöz intraepitelyal lezyon (HSIL) ve servikal kanser bulguları saptanan ve HPV DNA analizi yapılan hastaların sonuçları ve dosya bilgilerinde yer alan diğer veriler yeniden değerlendirilmiştir. İstatistiksel analiz için Ki-kare testi kullanılmıştır ve p<0.05 değerleri anlamlı kabul edilmiştir. Bulgular: 1050 hastanın 139’unda LSIL, 170’inde HSIL ve 112’sinde servikal kanser olduğu görülmüştür. En fazla LSIL, HSIL ve kanser görülme oranı 30-39 yaş grubunda izlenirken, 50-59 yaş grubunda bu hastalıkların oranının diğer yaş gruplara göre daha düşük olduğu izlenmiştir. Ayrıca SIL ve kanser görülen tüm hastalar sigara kullanmaktadır.1050 hastanın 240’ında HR HPV DNA testi pozitiftir. Smear sonuçlarına göre LSIL tanısı alan 56 hasta ve HSIL tanısı alan 89 hastada HR HPV DNA testi pozitiftir. Servikal kanser görülen 112 hastanın 74’ünde HR HPV DNA pozitifliği rapor edilmiştir. Smear sonuçları normal olan 21 hastanın HR HPV testlerinde pozitiflik bulunmuştur. Bu hastaların 17’si 30-39 yaş grubunda 4‘ü 40-49 yaş grubundadır. Sonuçlar: Bizim çalışmamızda kanser görülen 112 hastanın hepsinde HR HPV DNA’nın pozitif olmaması ve 21 HR HPV DNA pozitif hastanın smear sonuçlarının normal olması...
- 27 March 2023
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 4 (2) , 158-162
Open AccessHPV DNA pozitif olguların servikal smear ile korelasyon sonuçları her zaman uyumlu mudur?
Aim: Cervical cancer is a type of genital cancer which come second after breast cancer in women and may cause death. However, it can be prevented with screening tests by ensuring early diagnosis. Most of cervical cancers (99.7%) are associated with Human Papilloma Virus (HPV) and it is known that HPV must be present for the generation of cervical cancer. Thus, 70% of the patients have been found to be positive for HPV-16 and HPV-18. Both the association with cervical cancer and HPV and data related to development of cancer and dysplasia was researched retrospectively in this study. It was aimed to analyze and use the results by examine if the smear results of the patients and the HPV results are compatible in all HPV positive cases. Material and Method: 1050 patients who were examined by gynecologist and taken Pap smear test at the end of the examination during July 2020 and March 2022, were included in our study. In all cases the Pap test was re-evaluated by the same pathologist using the 2014 Bethesda System. High-risk HPV (HR HPV) DNA (HPV types 16,18,31,33,35,39,45,51,52,56,58,59,66,68) tests results, applied to the patients at an external center, were reviewed. Results of patients diagnosed as LSIL, HSIL and cervical cancer by Pap smear test were evaluated again beside HPV DNA analyses and their clinical information. Chi-square test was used for statistical analysis. p<0.05 values were considered statistically significant. Results: Of 1050 patients, 139 had LSIL, 170 had HSIL, and 112 had cervical cancer. The highest incidence of LSIL, HSIL and cancer was observed in the 30-39 age group, while the rate of these diseases was lower in the 50-59 age group compared to other groups. In addition, all patients with SIL and cervical cancer had smoking history. HR HPV DNA test was positive in 240 of 1050 patients. 56 patients diagnosed as LSIL and 89 patients diagnosed as HSIL by Pap smear had positive HR HPV DNA test results. HR HPV DNA positivity was reported in 74 of 112 patients with cervical cancer. In 21 patients who had normal smear test were detected HR HPV DNA positivity. 17 of these patients were in the 30-39 age group and 4 of them were in the 40-49 age group. Conclusions: Because of all 112 patients with cancer were not HR HPV positive and the smear results of 21 HR HPV positive patients were normal, our study serves an example for studies to show that the results of smear and HPV DNA in cervical cancer are not always compatible. Amaç: Serviks kanseri, ölüme neden olan ve meme kanserinden sonra kadınlarda en sık görülen ikinci kanserdir. Ancak tarama testleri ile erken teşhis edilerek önlenebilen bir genital kanser türüdür. Serviks kanserlerinin çoğu (%99,7) Human Papilloma Virus (HPV) ile ilişkili olup günümüzde de servikal kanser gelişimi için HPV’nin mutlaka olması gerektiği bilinmektedir. Nitekim hastaların %70’inde HPV-16 ve HPV-18’in pozitif olduğu tespit edilmiştir. Bu çalışmada servikal kanser-HPV ilişkisi, displazi ve kanser gelişme oranları ile ilgili veriler retrospektif olarak araştırılmıştır. HPV pozitif tüm olgularda hastaların smear sonuçları ile HPV sonuçlarının uyumlu olup olmadığı kontrol edilerek sonuçların analiz edilmesi ve kullanılması planlanmıştır. Materyal ve Metod: Çalışmaya Temmuz 2020 ve Mart 2022 tarihleri arasında jinekolog tarafından muayeneleri yapılmış ve muayene sonunda Pap smear örneği alınmış 1050 olgu dahil edilmiştir. Tüm olguların Pap smear testleri patolog tarafından 2014 Bethesda sistemi kullanılarak yeniden değerlendirilmiştir. Çalışmada yer alan hastalara dış merkezde uygulanan yüksek risk HPV (HR HPV) DNA (HPV tipleri 16,18,31,33,35,39,45,51,52,56,58,59,66,68) test sonuçları tekrar gözden geçirilmiştir. Pap testte düşük dereceli skuamöz intraepitelyal lezyon (LSIL), yüksek dereceli skuamöz intraepitelyal lezyon (HSIL) ve servikal kanser bulguları saptanan ve HPV DNA analizi yapılan hastaların sonuçları ve dosya bilgilerinde yer alan diğer veriler yeniden değerlendirilmiştir. İstatistiksel analiz için Ki-kare testi kullanılmıştır ve p<0.05 değerleri anlamlı kabul edilmiştir. Bulgular: 1050 hastanın 139’unda LSIL, 170’inde HSIL ve 112’sinde servikal kanser olduğu görülmüştür. En fazla LSIL, HSIL ve kanser görülme oranı 30-39 yaş grubunda izlenirken, 50-59 yaş grubunda bu hastalıkların oranının diğer yaş gruplara göre daha düşük olduğu izlenmiştir. Ayrıca SIL ve kanser görülen tüm hastalar sigara kullanmaktadır.1050 hastanın 240’ında HR HPV DNA testi pozitiftir. Smear sonuçlarına göre LSIL tanısı alan 56 hasta ve HSIL tanısı alan 89 hastada HR HPV DNA testi pozitiftir. Servikal kanser görülen 112 hastanın 74’ünde HR HPV DNA pozitifliği rapor edilmiştir. Smear sonuçları normal olan 21 hastanın HR HPV testlerinde pozitiflik bulunmuştur. Bu hastaların 17’si 30-39 yaş grubunda 4‘ü 40-49 yaş grubundadır. Sonuçlar: Bizim çalışmamızda kanser görülen 112 hastanın hepsinde HR HPV DNA’nın pozitif olmaması ve 21 HR HPV DNA pozitif hastanın smear sonuçlarının normal olması...